Dr. Reddy's Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript

Dr. Reddy's Laboratories (RDY)

Q1 2013 Earnings Call

July 19, 2012 9:00 am ET

Executives

Kedar Upadhye - Former Director

Umang Vohra - Chief Financial Officer, Executive Vice President and Member of Management Council

Kallam Satish Reddy - Managing Director, Chief Operating Officer, Executive Director, Member of the Management Council, Chairman of Management Committee, Member of Shareholders Grievance Committee, Member of Investment Committee and Member of Strategy Committee

Analysts

Balaji V. Prasad - Barclays Capital, Research Division

Nimish Mehta - MP Advisors

Arvind Bothra - BofA Merrill Lynch, Research Division

Ravi K. Agrawal - Standard Chartered plc, Research Division

Manoj Garg - Edelweiss Capital Ltd., Research Division

Sameer Baisiwala - Morgan Stanley, Research Division

Anubhav Aggarwal - Crédit Suisse AG, Research Division

Bino Pathiparampil - IIFL Research

Bhavin Shah - Dolat Investments Ltd., Research Division

Ranjit Kapadia - Centrum Broking Private Limited, Research Division

Nitin Agarwal - IDFC Securities Ltd., Research Division

Abhay Shanbhag - Deutsche Bank AG, Research Division

Saion Mukherjee - Nomura Securities Co. Ltd., Research Division

Chirag Talati - Espirito Santo Investment Bank, Research Division

Presentation

Operator

Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q1 FY '13 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to hand over the conference to Mr. Kedar Upadhye. Thank you, and over to you, sir.

Kedar Upadhye

Good morning, and good evening to all, and thank you for joining us today for Dr. Reddy's Earnings Call for quarter 1 of fiscal '13.

If you liked this article you might like

Generics Drop Across Board as DOJ Inquiry Expands

Teva Divests More Assets to Win EC Approval for Allergan Generics Deal

Changing Landscape for Generic-Drug Makers Creates Opportunities

Dr Reddy's Laboratories (RDY) Highlighted As Weak On High Volume

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: GLV, GLO, RDY